Introduction
Systemic sclerosis (SSc) is an autoimmune connective tissue disorder that is characterized by a complex interplay of vascular abnormalities, immune system activation, and an uncontrolled fibrotic response. The vascular component is often referred to as vasculopathy and is thought to have a key role in the early pathogenesis of SSc. Patients with SSc develop a broad spectrum of vascular manifestations, including Raynaud's phenomenon (RP) (distal vasospasm), which is almost universal, digital ulcers, which are common, and critical digital ischemia, which is rare. In parallel, within this very heterogeneous disease, some patients will develop vascular diseaserelated organ damage leading to heart or kidney failure (1) (2) (3) . It is still unclear whether there is a continuum between peripheral vasculopathy promoting digital ulceration, or critical ischemia, and some other vascular diseaserelated complications (4, 5) . The objective of this review is to address this question by analyzing whether severe digital vasculopathy could be a surrogate for vasculopathy elsewhere. The various sources of information used to answer this research question are shown in Figure 1 .
Generalized microvascular damage, from RP to obliterated small vessels SSc vasculopathy depends on the complex interaction of various pathologic processes including autoimmunity, impaired compensatory vasculogenesis and angiogenesis, endothelial-mesenchymal transition, endothelial dysfunction, and an impaired coagulation/fibrinolysis system. SSc vasculopathy is characterized by a variety of such changes that affect primarily the microcirculation and small arterioles (4, 5) . Disease in larger vessels can occur in SSc (6) , although there are still some debates about the risk of atherosclerosis in SSc (7) . That topic is beyond the scope of this review, which focuses primarily on the potential risk of generalized microangiopathy and a potential continuum between digital ulcers and organ-based vasculopathy.
The hallmark of functional abnormalities related to SSc vasculopathy is RP. It is characterized by exaggerated but reversible vasospasm in response to cold exposure, stress, or emotional upset. Vascular tone dysfunction is mainly attributable to impaired endothelial function. Several studies have shown reduced flow-mediated dilation values, supporting the notion of impaired nitric oxide production (8) . It must be pointed out that although impaired endothelial function is mainly recognized at the digital level, it is well established that all microcirculatory systems can be affected (4, 5) . For example, cardiac imaging showed abnormal perfusion related to small coronary artery disturbances after cold stress (7) .
With the progression of structural vascular changes, functional alteration of vascular cells includes endothelial cell apoptosis, impaired coagulation/fibrinolysis system, aberrant expression of soluble factors and cell adhesion molecules, leading to the pathologic inflammation. During this phase, perivascular infiltrates are evident, endothelial cells, pericytes, and vascular smooth muscle cells proliferate, endothelial-mesenchymal transition takes place, and myofibroblasts are activated in the dermal tissue (9) . The next steps include altered neovascularization and vascular remodeling due to impairment of compensatory vasculogenesis and exaggerated angiogenesis (10) (11) (12) (13) (14) (15) (16) . Circulating levels of various angiogenic/angiostatic factors are largely altered and, so far, most studies have shown that proangiogenic factor levels are increased throughout the disease course, especially during the active stage (17, 18) . The progression of these events leads to intima and media fibroproliferation, which will provoke microvessel obliteration. Consequently, chronic hypoxia may further promote fibrosis of the surrounding tissue (16) . Early damage to the endothelium, together with the vascular instability and the chronic hypoxia generating reactive oxygen species, thus have a downstream deleterious effect on capillaries (17) . This leads eventually to aberrant angiogenesis and progressively to a loss of capillaries. The vessel obliteration will further progress to tissue anoxia, which will have a devastating effect on the extremities, with tissue necrosis and gangrene (17) . Taken together, these findings support the notion of generalized microvascular impairment in SSc. It is reasonable to ask why the digits might be primarily affected, but exposure to cold in this area could result in more important and/or earlier damage, which could explain the high risk for the development of digital ischemia and ulceration. Nevertheless, the pathogenesis of the vasculopathy, the findings of abnormal circulating markers as previously highlighted, such as the inverse correlation between flow-mediated dilation values and pulmonary artery pressure (PAP) and the association of decreased flow-mediated dilation values with the presence of pulmonary arterial hypertension (PAH) and digital ulcers, indicate the presence of a generalized vascular abnormality (19, 20) . Therefore, the natural course of the disease should be evaluated more deeply to determine whether the proliferative and obliterative vasculopathy may gradually and sometimes subclinically progress along with disease duration, eventually becoming clinically evident, with variable tonality of severe vessel involvement. This may thus lead to periodic or recurrent digital ulcers, PAH, heart failure, and renal function decline or renal crisis.
Data from cross-sectional studies of risk factors and vascular complications in SSc patients with digital ulcers
To investigate the clinical vascular manifestations occurring in SSc patients with digital ulcers, the characteristics of patients with digital ulcers versus those without digital ulcers (extracted from publications of large cross-sectional series) were analyzed.
In a French multicenter study, a cross-sectional analysis of 599 patients with SSc (the Itin erAIR-Scl erodermie cohort) showed that 53% of these patients had prior or current digital ulcers (21) . When associated variables were considered, digital ulceration appeared to occur more frequently in male patients, patients with a higher modified Rodnan skin thickness score (MRSS) (22) , patients with early onset of disease, patients with a diffusing capacity for carbon monoxide (DLCO) of <60% predicted, and patients with anti-topoisomerase I antibodies. It must be highlighted that sex and skin disease were the variables with the strongest associations. The frequency of PAH was not higher in patients with prior or current digital ulcers than in those who were never affected (21) . DLCO measures gas exchanges through the alveolar membrane and can be influenced by the thickness of the alveolar membrane and lung capillary volume. Therefore, a reduced DLCO in the absence of impairment in pulmonary function (forced vital capacity [% predicted]) may represent a surrogate marker of vasculopathy. The associations with DLCO impairment, worsening of RP, and recurrent digital ulcers indicate the pathophysiologic link between the involvement of 2 different endothelial systems, the lungs and the digits. However, no relationship between prior or current digital ulcers and PAH was observed in the French study (21) .
The German Network for Systemic Scleroderma (23) has provided data for 1,880 patients, among whom 1,690 were evaluable for digital ulcers. Among these patients, 408 (24%) had digital ulcers at the time of entry into the registry. In multivariate analyses, data sets for 1,164 patients were used and revealed that male sex was the most powerful independent predictor of the presence of digital ulcers, and that PAH, anti-Scl-70 antibodies (but not anticentromere antibodies [ACAs]), involvement of the mouth or esophagus, an elevated erythrocyte sedimentation rate, and onset of RP at a young age were all risk factors for the presence of digital ulcers. Diffuse skin sclerosis in combination with PAH was the most powerful predictor for the occurrence of digital ulcers.
In a Spanish study, a total of 19 referral centers participated in the recruitment of 1,326 SSc patients (24) . Among these patients, 552 had prior or current digital ulcers. Multivariate analysis showed that the presence of prior/current digital ulcers was independently associated with younger age at SSc diagnosis, diffuse cutaneous SSc (dcSSc), and the presence of peripheral vascular manifestations such as RP, telangiectasia, and acroosteolysis. However, a history of digital ulcers was not associated with any visceral vasculopathy such as PAH or scleroderma renal crisis.
The Canadian Scleroderma Research Group (25) investigated the features associated with digital ulcers and their complications and sought to determine whether digital ulceration was associated with PAH and scleroderma renal crisis. Among 938 SSc patients, 8% had a current digital ulcer, 44% had a digital ulcer ever, and 53% had digital pitting scars. In the multivariate analysis, the most important variables predictive of digital ulcers were younger age at disease onset, interstitial lung disease, higher hand and finger skin scores, and a higher Health Assessment Questionnaire (26) score. There was no significant association between a history of digital ulcers and any definition of PAH (prevalence 9%) or with renal crisis (prevalence 5%).
If microcirculation impairment is fundamental in SSc vasculopathy, large vessel disease may overlap and contribute to tissue damage, although the potential role of atherosclerosis in SSc-related vascular damage is still being debated. In a Japanese cross-sectional study (27) , 164 ALLANORE ET AL the association of carotid artery atherosclerosis with digital ulcers was examined by comparing SSc patients with digital ulcers (n = 48 [29.5%]) and those without digital ulcers (n = 206 [70.5%]). No multivariable analysis was performed, but it is of interest to point out that carotid atherosclerosis was not more common in SSc patients with digital ulcers than in those without digital ulcers. Regarding SSc characteristics, digital ulcers were more common in male patients and in those with dcSSc, and the MRSS was higher in patients with a history of digital ulcers, confirming previously reported findings in patient populations in other geographic regions (28) . An evaluation of heart disease showed that the incidence of PAH was not higher in SSc patients with digital ulcers than in those without digital ulcers (9% and 10%, respectively). After exclusion of the patients with PAH, those with digital ulcers more commonly had elevated levels of natriuretic peptide or milder cardiac abnormalities such as electrocardiographic changes or coronary artery disease. Cutaneous telangiectasias are common in SSc and are part of the American College of Rheumatology/European League Against Rheumatism (EULAR) 2010 classification criteria for rheumatoid arthritis (29) . A previous cross-sectional study (30) was performed to determine whether the number and size of cutaneous telangiectasias were associated with the pattern of microvascular lesions assessed by nailfold videocapillaroscopy and markers reflecting the severity of SSc-related vasculopathy.
Among 87 patients, both profuse and pseudotumoral cutaneous telangiectasias were associated with capillary loss and severe dysangiogenesis on nailfold videocapillaroscopy. In a multivariate analysis, profuse pseudotumoral cutaneous telangiectasias were independently associated with past or current digital ulcers, whereas pseudotumoral cutaneous telangiectasias were independently associated with the late nailfold videocapillaroscopy pattern and PAH (31) . Of most interest, a previous study showed some association between telangiectasias and PAH; the adjusted relative odds of PAH was 12.4 for patients with a 10-point increase in the telangiectasia score (30) . These 2 studies emphasized telangiectasia as being a potential clinical marker of more widespread aberrant microvascular disease in SSc. Regarding renal crisis, another vascular organ complication, few studies address the risk factors for renal crisis; however, none of these studies suggested that digital ulcers or PAH may be a risk factor for such an event (31) .
The results of the main studies described above are summarized in Table 1 ; the associations observed in multivariable analyses are highlighted. Overall, even with the limitation of cross-sectional designs, these studies showed that digital ulcers were more common in patients with early-onset SSc, in male patients, in those with dcSSc, and in association with a high MRSS, but they did not consistently show a higher risk of PAH, heart failure, or renal crisis in patients with digital ulcers compared with those without digital ulcers. 
Not studied Not studied + Not studied * NA = not available; MRSS = modified Rodnan skin thickness score; anti-topo = antitopoisomerase; ESR = erythrocyte sedimentation rate; DLCO = diffusing capacity for carbon monoxide; HAQ = Health Assessment Questionnaire. † Prevalence 53%. ‡ Prevalence 24%. § Prevalence 44%. ¶ Prevalence 42%. # Only diffuse cutaneous systemic sclerosis (SSc).
DIGITAL ULCERS AND OTHER VASCULAR COMPLICATIONS IN SSc
Data from longitudinal studies of vascular complications in SSc patients with digital ulcers
Another way to investigate whether digital ulcers may be a surrogate for generalized vasculopathy is to examine prospective data to determine whether SSc patients with digital ulcers at baseline develop more organ vasculopathy compared with patients who are not affected.
A study looking at the natural history of SScrelated digital ulcers was based on 103 patients, among whom 46 had a history of digital ulcers (32) . The mean duration of follow-up after the first non-RP symptom of SSc was~12 years. The first digital ulcer occurred within 1 year following the first non-RP symptom in 43% of patients and within 5 years in 73% of patients. A multivariable analysis showed that in SSc patients who were younger when the first non-RP symptom occurred and in patients with a higher MRSS (21) (e.g., those classified as being in the dcSSc subset), digital ulcers occurred earlier. It must also be pointed out that the first digital ulcer manifestation was delayed when vasodilator therapy was given (mainly calcium-channel blockers or angiotensinconverting enzyme inhibitors). PAH occurred in 11 patients (11%) during the course of the disease, and its prevalence was comparable between the SSc patients in the subgroup with PAH and the subgroup with no digital ulcers (14% and 9%, respectively; P = 0.53) (31).
One of the main studies that highlighted the link between DLCO and vasculopathy used the Pittsburgh Scleroderma Databank to match 106 patients who had a diagnosis of PAH with 106 subjects according to SSc skin subtype, age, sex, race, disease duration, and mean time to the diagnosis of PAH after the initial visit. If a decline in DLCO occurred before a diagnosis of PAH, patients with PAH and controls had a similar frequency of RP, digital tip ulcers, and digital gangrene. However, visual analog scales showed that patients had significantly higher values for both the severity of RP and the severity of digital tip ulcers (33) .
In the EULAR Scleroderma Trials and Research (EUSTAR) cohort, it was shown that at presentation, 1,092 of 3,196 patients (34%) had a history of digital ulcers. Follow-up of 3 years was the cutoff time for determining the occurrence of complications (34) . In multivariable analyses adjusting for age, sex, and other parameters that were considered to be potentially significant, a history of digital ulcers was strongly predictive for the presence of digital ulcers at prospective visits but also for an elevated systolic PAP on heart ultrasound, for any cardiovascular event (new digital ulcers, elevated systolic PAP by echocardiography, left ventricular failure, and death). Overt PAH could not be analyzed, and there was no prediction for renal crisis (34) .
In the Australian Scleroderma Interest Group PAH registry, among 1,636 patients with SSc, 194 (12%) had PAH proven by right-sided heart catheterization; among these patients, 160 were detected prospectively by screening (35) . The study primarily reviewed the outcomes of patients according to the screening programs, but the characteristics of SSc-related PAH were detailed and analyzed using univariate analyses. The data showed that SSc patients with PAH were older, had a longer disease duration from the first non-RP clinical manifestation, were more likely to be positive for ACAs, and to have telangiectasia, calcinosis, and joint contractures. Furthermore, digital ulcers were more frequent in patients with PAH (53% in patients with SSc-related PAH and 42% in SSc patients without PAH), but the strength of association was not very great, and only multivariable analyses could clarify whether the various variables associated in univariate analyses are independently associated if they are still associated in the multivariable model. Therefore, their independence can be demonstrated only by multivariate analyses.
The German investigators also reviewed prospective data regarding digital ulcers and showed various degrees of progression according to SSc characteristics (36) . Unfortunately, no details were provided for other outcomes, with the exception of a statement that the weak or lack of association of digital ulcers with PAH or heart and renal involvement indicates that vasculopathy in digital arteries and the renal and pulmonary vasculature seems to be affected by different pathophysiologic pathways.
As opposed to the cross-sectional analyses, the available longitudinal data appeared to support some links between baseline digital ulcers and the subsequent risk of more severe vasculopathy defined by recurrent digital ulcers but also the risk of PAH. The low frequency of renal crisis and heart failure limits the possibility of identifying such links, but the large EUSTAR registry supports a predictive value of baseline digital ulcers for overall cardiovascular complications. Confirmation will have to be investigated in the future using new database extracts that may contain more patients with a longer follow-up.
Vascular biomarker studies
In recent years, many studies have investigated candidate vascular biomarkers. Although some of these studies were mainly descriptive, using cross-sectional designs, others were based on longitudinal data, allowing prediction of overall vascular risk (37) .
The pentraxins are a highly conserved family of proteins with a unique architecture. In humans, the 2 main 166 ALLANORE ET AL members of this family are C-reactive protein and serum amyloid P. Pentraxin 3 (PTX3) is expressed predominantly in atherosclerotic lesions that involve various cells such as macrophages, neutrophils, dendritic cells, or smooth muscle cells. Interestingly, PTX3 has been examined as a novel biomarker for inflammatory cardiovascular disease. In SSc, circulating levels of PTX3, but also fibroblast growth factor 2 (FGF-2), have been shown to be significantly higher in SSc patients than in healthy control subjects (38) . Of most interest is the observation that the PTX3 level was elevated in SSc patients who had digital ulcers or PAH, while the level of FGF-2 was reduced in SSc patients with PAH. Multivariate analysis identified an elevated PTX3 level as an independent parameter associated with the presence of digital ulcers and PAH. Furthermore, PTX3 levels were a useful predictor of future occurrences of digital ulcers, and reduced FGF-2 levels were independently associated with the presence of PAH. Chemokine CXCL4 levels have been demonstrated to be correlated with skin and lung fibrosis and also with PAH (39) . No data regarding digital ulcers were provided, but among chemokines, only CXCL4 predicted the risk and progression of SSc.
In a prospective cohort of 100 SSc patients who were followed up for 3 years, vascular biomarkers of new events were investigated, primarily to predict the development of new digital ulcers, which occurred in 17 SSc patients. Both angiogenic and vasculogenic markers were measured. Based on various multivariable models, a history of digital ulcers, but also placenta growth factor (PlGF) levels and the endothelial progenitor cell count, were independent predictors of the development of digital ulcers (40) . The prediction of other cardiovascular end points was studied, suggesting stimulating clues with these markers, but the number of events was low, which limited statistical power. Interestingly, another study confirmed the promise of PlGF as well as Flit-1 as measures of pulmonary hypertension in SSc (41) .
Functional autoantibodies are directed against the vascular receptors angiotensin II receptor type 1 (AT 1 ) and endothelin 1 type A receptor (ETAR). A majority of SSc patients have increased levels of anti-ETAR and anti-AT 1 antibodies compared with those in healthy donors. Moreover, in SSc patients, the autoantibodies are associated with various vascular symptoms of the disease, such as PAH, digital ulcers, and renal crisis. Nevertheless, the antibodies are also associated with dcSSc as well as lung fibrosis. Taken together, these data suggest a possible role of these antibodies in disease mechanisms, but their use in clinical practice for predicting damage remains to be established. In the context of digital ulcers, it has been shown that anti-ETAR autoantibodies can be used, together with the current or past presence of digital ulcers, to identify patients with SSc who are at risk for the development of subsequent digital ulcers (42, 43) .
Imaging may also provide some tools to predict digital ulcers and vascular outcomes. Although few studies have been performed so far, capillaroscopy has been shown to be an interesting candidate, and a prospective study with a 6-month duration showed that the mean number of capillaries per millimeter in the middle finger of the dominant hand, the number of digital ulcers at enrollment, and the presence of critical digital ischemia at enrollment were risk factors for the development of new digital ulcers. Other cardiovascular outcomes were not measured for a duration of 6 months (44).
The carotid-femoral pulse wave velocity (PWV) is a marker of aortic stiffness that holds prognostic significance in various vascular conditions, including systemic hypertension, renal failure, and heart failure. The augmentation index standardized to a heart rate of 75/minute (Aix_75), defined as the amplitude of the reflected wave from the periphery to the heart, can be measured by applanation tonometry and depends on several factors, including large artery (but also medium and small artery) stiffness. Radial applanation tonometry was performed in a group of 63 SSc patients to investigate an association of PWV or the Aix_75 with digital ulcers in 10 SSc patients. At baseline, there were no differences between SSc patients with digital ulcers and those without digital ulcers with regard to the cutaneous subset of SSc, disease duration, renal and pulmonary function, cardiovascular risk factors, heart function, and PAP (45) . SSc patients with digital ulcers had an increased Aix_75 compared with patients without digital ulcers, while there was no difference in PWV. The results of the multivariate logistic regression revealed that age, sex, erythrocyte sedimentation rate, aortic pulse pressure, and digital ulcers were independently associated with the Aix_75 (45) .
Collectively, these results suggest the existence of increased stiffness of small and medium arteries in SSc patients with digital ulcers, without significantly increased aortic stiffness when compared with SSc patients without digital ulcers. The predictive value of such a tool on broader cardiovascular outcomes and in a larger population would be of interest.
Conclusions
Vascular injury and subsequent vascular dysfunction are among the earliest alterations in SSc and are considered to act within the initiating steps in SSc pathogenesis. Microcirculation impairment, the hallmark of the disease, may also spread to larger vessels, even if the reality of an increased prevalence of atherosclerosis in SSc remains controversial. The disease process is undoubtedly generalized, and all microvascular territories are affected. This notion is strongly supported by autopsy studies that showed lung and kidney vessel involvement despite the lack of any evidence of organ involvement (46) . It is well known that among all vascular complications, digital ulcers are the most common clinical expression of advanced vasculopathy. It remains unclear why the digits are affected most, although permanent exposure to external stress might contribute to the severity. Some investigators have speculated that digital ulcers could be a clinical marker of tissue damage (vascular and fibrotic changes), but epidemiologic studies do not clearly and reproducibly demonstrate a strong link between digital ulcers and other vascular complications. Indeed, crosssectional studies show that SSc patients with digital ulcers have more severe disease, but a higher frequency of PAH or renal crisis has not been observed. Longitudinal studies further support poorer outcomes in SSc patients with digital ulcers, and some of these studies suggest a predictive value of baseline digital ulcers for subsequent digital ulcers or even PAH or overall cardiovascular complications. Currently, however, several methodologic issues preclude firm conclusions. Indeed, the definition of the events differs between studies, the time of observation is usually not very long for PAH (which is usually a late complication), and because of the scarcity of major cardiovascular events, the sample size may be an issue.
Biomarker studies highlight the systemic component of vasculopathy and suggest some links between digital ulcers and PAH, although it appears that additional further and potential regional factors might contribute to more severe remodeling in the finger, lungs, or kidneys. Autoantibodies might contribute to these specificities, and it is of interest to observe that digital ulcers are more common in patients with dcSSc and probably those who are positive for antitopoisomerase antibodies, whereas ACAs are reproducibly found in patients with SSc-related PAH, and that anti-RNA polymerase III antibodies are strong markers for renal crisis. The roles of other autoantibodies that could be functional autoantibodies are interesting clues in this context.
Regarding therapy for vascular SSc, several PAH drugs are available for the treatment of SSc-related PAH, but the drugs are given to patients who have already developed histologically very advanced vasculopathy. At a less severe stage of vasculopathy, calciumchannel blockers and iloprost are licensed for the treatment of severe RP and bosentan is licensed for prevention of digital ulcers. Clinical trials have shown the respective beneficial effects of these agents, but the duration of the trials was short, with a relatively small number of selected patients. Therefore, the effects on other vascular outcomes could not be reliably measured. Scarce data are available from long-term observational studies, but the results of several studies suggested that long-term iloprost treatment may reduce the progression of vascular complications (47, 48) , and that long-term use of calcium-channel blockers could reduce heart or kidney disease progression (49, 50) . Although such results could support the notion of a continuum in vasculopathy, because these data are very preliminary, no definite conclusion can be drawn.
One might add that the natural course of vasculopathy and its complications has changed. Indeed, in recent years, the clinical trials of digital ulcer recurrence showing both faster healing and fewer relapses of digital ulcers in SSc patients are encouraging new research to better understand SSc-related vascular outcomes and update its management (51) (52) (53) . Therefore, SSc patients with digital ulcers have worse outcomes compared with patients without digital ulcers, and patients with digital ulcers should be managed as having a severe form of the disease (54) . However, the reason why vasculopathy may be mainly expressed in digital arteries in some patients and in pulmonary or kidney arteries in others remains unclear. Improving knowledge in the field would distress this part of the disease, which is a huge contributor to excessive morbidity and mortality.
